| First Author | Subudhi I | Year | 2024 |
| Journal | Immunity | PubMed ID | 38772365 |
| Mgi Jnum | J:349809 | Mgi Id | MGI:7658806 |
| Doi | 10.1016/j.immuni.2024.04.022 | Citation | Subudhi I, et al. (2024) Metabolic coordination between skin epithelium and type 17 immunity sustains chronic skin inflammation. Immunity |
| abstractText | Inflammatory epithelial diseases are spurred by the concomitant dysregulation of immune and epithelial cells. How these two dysregulated cellular compartments simultaneously sustain their heightened metabolic demands is unclear. Single-cell and spatial transcriptomics (ST), along with immunofluorescence, revealed that hypoxia-inducible factor 1alpha (HIF1alpha), downstream of IL-17 signaling, drove psoriatic epithelial remodeling. Blocking HIF1alpha in human psoriatic lesions ex vivo impaired glycolysis and phenocopied anti-IL-17 therapy. In a murine model of skin inflammation, epidermal-specific loss of HIF1alpha or its target gene, glucose transporter 1, ameliorated epidermal, immune, vascular, and neuronal pathology. Mechanistically, glycolysis autonomously fueled epithelial pathology and enhanced lactate production, which augmented the gammadelta T17 cell response. RORgammat-driven genetic deletion or pharmacological inhibition of either lactate-producing enzymes or lactate transporters attenuated epithelial pathology and IL-17A expression in vivo. Our findings identify a metabolic hierarchy between epithelial and immune compartments and the consequent coordination of metabolic processes that sustain inflammatory disease. |
